DCF — MANHATTAN SURGICAL HOSPITAL
Enterprise Value: $49.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$49.2M
Enterprise Value
$13.4M
PV of Cash Flows
$35.8M
PV of Terminal Value
$57.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $43.3M | $5.9M | 14.0% | $2.9M | $2.6M |
| Year 2 | $44.6M | $6.5M | 15.0% | $3.3M | $2.7M |
| Year 3 | $45.9M | $7.2M | 16.0% | $3.7M | $2.8M |
| Year 4 | $47.3M | $7.6M | 16.0% | $4.0M | $2.7M |
| Year 5 | $48.7M | $8.0M | 16.0% | $4.2M | $2.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $49.2M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$42.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.13091503132551524
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5